¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"receptor aggregation"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
aggregation
ÀÀÁý
platelet aggregation
Ç÷¼ÒÆÇÀÀÁý
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen receptor
Ç׿ø¼ö¿ëü
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
¾Èµå·Î°Õ¼ö¿ëü
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈÈ¿¼Ò
cold receptor
³Ã°¢¼ö¿ë±â
complement receptor
º¸Ã¼¼ö¿ëü
corpuscular receptor
¼Òü¼ö¿ëü
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
distance receptor
¿ø°Ý¼ö¿ë±â
dominant receptor
¿ì¼º¼ö¿ëü
early receptor potential
Á¶±â¼ö¿ëüÀüÀ§, Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
9
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
aggregation
ÀÀÁý
platelet aggregation
Ç÷¼ÒÆÇÀÀÁý
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
receptor binding
¼ö¿ëü°áÇÕ
receptor
¼ö¿ëü, ¼ö¿ë±â
antigen receptor
Ç׿ø¼ö¿ëü
opiate receptor
¾ÆÆí¼ö¿ëü
sensory receptor
°¨°¢¼ö¿ëü
receptor site
¼ö¿ëüºÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
aggregation
ÀÀÁý
aggregation defect
ÀÀÁý°áÇÔ
platelet aggregation
Ç÷¼ÒÆÇÀÀÁý
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
¾Èµå·Î°Õ¼ö¿ëü
antigen receptor
Ç׿ø¼ö¿ëü
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
receptor autoradiography
¼ö¿ëüÀÚ°¡¹æ»ç¼±¼ú
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈÈ¿¼Ò
receptor binding
¼ö¿ëü°áÇÕ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
cold receptor
³Ã°¢¼ö¿ëü
complement receptor
µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
aggregation
ÁýÇÕ(ó¢ùê), ÀÀ±«(ëêÎÔ)
platelet aggregation
Ç÷¼ÒÆÇÀÀÁý
platelet,aggregation
ÀÀÁý(ëêó¢), ÀÀ±«(ëêÎÔ)
A1 receptor
A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
A2 receptor
A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
CR1 => complement receptor 1
º¸Ã¼¼ö¿ëü 1
CR2 => complement receptor 2
º¸Ã¼¼ö¿ëü 2
CR3 => complement receptor 3
º¸Ã¼¼ö¿ëü 3
CR4 => complement receptor 4
º¸Ã¼¼ö¿ëü 4
Gustatory receptor
¹Ì°¢¼ö¿ëü(Ú«ÊÆâ¥é»ô÷)
H2 receptor antagonist
H2 ¼ö¿ëü ±æÇ×Á¦µé
Ig receptor
¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
Internalization, receptor
³»È(Ò®ü§), ¼ö¿ëü(áôé»ô÷)
Kainate amino acid receptor
Ä«À̳×ÀÌÆ® ¾Æ¹Ì³ë»ê ¼ö¿ëü(áôé»ô÷)
Kinesthetic receptor
¿îµ¿(ê¡ÔÑ)(°¨(Êï))°¢¼ö¿ëü(ÊÆáôé»ô÷)
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
aggregation
ÁýÇÕ(ó¢ùê), ÀÀ±«(ëêÎÔ)
aggregation defect
ÀÀÁý°áÇÔ
intravascular erythrocyte aggregation =IEA
Ç÷°ü³»ÀûÇ÷±¸ÀÀÁý(?ËøÌ´Ë´Ëô̤).
platelet aggregation
Ç÷¼ÒÆÇÀÀÁý
platelet,aggregation
ÀÀÁý(ëêó¢), ÀÀ±«(ëêÎÔ)
ristocetin aggregation test
¸®½ºÅ似ƾÀÀÁý½ÃÇè(¡ëêó¢ãËúÐ)
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
acetylcholine receptor antibody assay
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
adrenergic receptor
¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â,°¨¼öü)
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
³²¼ºÈ£¸£¸ó ¼ö¿ëü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½